Phthalazinone derivatives

US7226923B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Edward Andrew Boyd · Biggenden, AU
• Frederick Arthur Brookfield · Woodstock, GB
• Guy Georges · Habach, DE
• Bernhard Goller · Penzberg, DE
• Sabine Huensch · Penzberg, DE
• Petra Rueger · Penzberg, DE
• Matthias Rueth · Penzberg, DE
• Stefan Scheiblich · Mainz, DE
• Christine Schuell · Penzberg, DE
• Wolfgang von der Saal · Rosenheim, DE
• Justin Warne · London, GB
• Stefan Weigand · Wuppertal, DE

Key dates

• Filing date: Sep 23, 2005
• Grant date: Jun 5, 2007
• Expiry date: Dec 2, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula Itheir pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates are disclosed. Also disclosed are methods for the preparation of the above-mentioned compounds, pharmaceutical compositions containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.